United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-931_26bd4975-008b-4029-b0da-3a75b0f7e0f4
Product NDC
71205-931
Form
TABLET
Composition / generic term
Gabapentin
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20160411
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (71205-931-00) · 71205-931-00
  • 30 TABLET in 1 BOTTLE (71205-931-30) · 71205-931-30
  • 500 TABLET in 1 BOTTLE (71205-931-55) · 71205-931-55
  • 60 TABLET in 1 BOTTLE (71205-931-60) · 71205-931-60
  • 240 TABLET in 1 BOTTLE (71205-931-64) · 71205-931-64
  • 270 TABLET in 1 BOTTLE (71205-931-67) · 71205-931-67
  • 120 TABLET in 1 BOTTLE (71205-931-72) · 71205-931-72
  • 360 TABLET in 1 BOTTLE (71205-931-76) · 71205-931-76
  • 180 TABLET in 1 BOTTLE (71205-931-78) · 71205-931-78
  • 90 TABLET in 1 BOTTLE (71205-931-90) · 71205-931-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →